1. Home
  2. MACI vs CATX Comparison

MACI vs CATX Comparison

Compare MACI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MACI
  • CATX
  • Stock Information
  • Founded
  • MACI 2024
  • CATX 1983
  • Country
  • MACI United States
  • CATX United States
  • Employees
  • MACI N/A
  • CATX N/A
  • Industry
  • MACI
  • CATX Medical/Dental Instruments
  • Sector
  • MACI
  • CATX Health Care
  • Exchange
  • MACI NYSE
  • CATX Nasdaq
  • Market Cap
  • MACI 227.5M
  • CATX 239.0M
  • IPO Year
  • MACI 2024
  • CATX N/A
  • Fundamental
  • Price
  • MACI $10.51
  • CATX $3.35
  • Analyst Decision
  • MACI
  • CATX Strong Buy
  • Analyst Count
  • MACI 0
  • CATX 11
  • Target Price
  • MACI N/A
  • CATX $12.90
  • AVG Volume (30 Days)
  • MACI 104.5K
  • CATX 1.9M
  • Earning Date
  • MACI 01-01-0001
  • CATX 08-11-2025
  • Dividend Yield
  • MACI N/A
  • CATX N/A
  • EPS Growth
  • MACI N/A
  • CATX N/A
  • EPS
  • MACI 0.33
  • CATX N/A
  • Revenue
  • MACI N/A
  • CATX $1,471,000.00
  • Revenue This Year
  • MACI N/A
  • CATX N/A
  • Revenue Next Year
  • MACI N/A
  • CATX N/A
  • P/E Ratio
  • MACI $31.93
  • CATX N/A
  • Revenue Growth
  • MACI N/A
  • CATX N/A
  • 52 Week Low
  • MACI $9.95
  • CATX $1.60
  • 52 Week High
  • MACI $10.83
  • CATX $16.55
  • Technical
  • Relative Strength Index (RSI)
  • MACI N/A
  • CATX 50.66
  • Support Level
  • MACI N/A
  • CATX $3.54
  • Resistance Level
  • MACI N/A
  • CATX $4.44
  • Average True Range (ATR)
  • MACI 0.00
  • CATX 0.40
  • MACD
  • MACI 0.00
  • CATX -0.04
  • Stochastic Oscillator
  • MACI 0.00
  • CATX 18.57

About MACI MELAR ACQUISITION CORP. I

Melar Acquisition Corp I is a blank check company.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: